Handelsbanken Fonder
BSX icon

Handelsbanken Fonder’s Boston Scientific BSX Stock Holding History

Handelsbanken Fonder’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.6M Sell
1,584,433
-1,002,628
-39% -$54.4M 0.19% 88
2026
Q1 		$162M Buy
2,587,061
+66,942
+3% +$5.36M 0.54% 27
2025
Q4 		$240M Buy
2,520,119
+263,737
+12% +$25.9M 0.73% 18
2025
Q3 		$220M Sell
2,256,382
-124,031
-5% -$12.8M 0.7% 19
2025
Q2 		$256M Sell
2,380,413
-281,890
-11% -$28.5M 0.91% 12
2025
Q1 		$269M Buy
2,662,303
+106,847
+4% +$10.8M 1.11% 13
2024
Q4 		$228M Buy
2,555,456
+184,049
+8% +$16.2M 0.87% 14
2024
Q3 		$199M Buy
2,371,407
+965,080
+69% +$76.1M 0.79% 17
2024
Q2 		$108M Buy
1,406,327
+190,584
+16% +$13.9M 0.47% 35
2024
Q1 		$83.3M Buy
1,215,743
+630,905
+108% +$40.6M 0.36% 55
2023
Q4 		$33.8M Buy
584,838
+36,042
+7% +$1.92M 0.16% 144
2023
Q3 		$29M Buy
548,796
+4,862
+0.9% +$255K 0.16% 144
2023
Q2 		$29.4M Buy
543,934
+39,425
+8% +$2.06M 0.16% 156
2023
Q1 		$25.2M Buy
504,509
+15,412
+3% +$726K 0.15% 168
2022
Q4 		$22.6M Buy
489,097
+64,158
+15% +$2.78M 0.14% 176
2022
Q3 		$16.5M Buy
424,939
+3,641
+0.9% +$146K 0.11% 201
2022
Q2 		$15.7M Buy
421,298
+26,893
+7% +$1.09M 0.1% 208
2022
Q1 		$17.5M Sell
394,405
-12,305
-3% -$533K 0.1% 212
2021
Q4 		$17.3M Sell
406,710
-7,649
-2% -$321K 0.09% 231
2021
Q3 		$18M Buy
414,359
+12,738
+3% +$564K 0.09% 221
2021
Q2 		$17.2M Buy
401,621
+45,735
+13% +$1.92M 0.09% 236
2021
Q1 		$13.8M Buy
355,886
+12,108
+4% +$458K 0.08% 242
2020
Q4 		$12.4M Buy
343,778
+3,534
+1% +$127K 0.08% 250
2020
Q3 		$13M Buy
340,244
+28,918
+9% +$1.11M 0.1% 210
2020
Q2 		$10.9M Buy
+311,326
New +$11.2M 0.09% 213
2016
Q1 		– Sell
-125,060
Closed -$2.31M – 275
2015
Q4 		$2.31M Buy
+125,060
New +$2.24M 0.04% 317

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Handelsbanken Fonder's BSX Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Boston Scientific (BSX) stake by 39% in Q2 2026, selling an estimated $54.4M and leaving 1,584,433 shares worth $67.6M. The position accounts for 0.19% of the portfolio, ranked #88.

Handelsbanken Fonder first reported a position in BSX in Q4 2015 and has held it in 26 quarters since. The position peaked at $269M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Handelsbanken Fonder held 1,584,433 shares of Boston Scientific worth $67.6M as of Q2 2026.
  • Handelsbanken Fonder sold 1,002,628 Boston Scientific shares in Q2 2026, an estimated $54.4M.
  • Boston Scientific made up 0.19% of Handelsbanken Fonder's portfolio in Q2 2026, its #88 holding.
  • Handelsbanken Fonder first reported a position in Boston Scientific in Q4 2015 and has held it in 26 quarters since.
  • Handelsbanken Fonder's Boston Scientific position peaked at $269M in Q1 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.